Pharma Consult ApS: Financial statements 2023
CVR: 43801708
Source: annual report 2023, Danish Business Authority
24/01/2023 – 31/12/2023
Pharma Consult ApS (CVR 43801708) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 1,454,116 and a net result of DKK 509,944. Equity in the 2023 report amounted to DKK 549,943. The solvency ratio was 62.2%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,454,116
- Profit/Loss
- DKK 509,944
- Equity
- DKK 549,943
- Total Assets
- DKK 884,753
- Employees
- 1
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of January 24, 2023, Shahin Jolaini is registered as adm. dir. of Pharma Consult ApS.
As of January 24, 2023, Shahin Jolaini is registered as an owner of Pharma Consult ApS with an ownership share of 100%.
Pharma Consult ApS was founded on January 24, 2023.
About Pharma Consult ApS
Pharma Consult ApS is a Danish company of the type Anpartsselskab based in Hillerød, founded in 2023. The company is registered under the industry Anden teknisk rådgivning. The management consists of Shahin Jolaini. The company is owned by Shahin Jolaini. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,148,461 and a net result of DKK 343,471 compared with DKK 462,291 the year before. Equity in the 2025 report amounted to DKK 1,355,705.